Investor Relations

At PRA Health Sciences, we work side-by-side with our clients, to move drug discovery forward, and to help them develop life-saving and life- improving drugs. For more than 30 years, we’ve been helping to bring to market everything from niche treatments and therapies to blockbuster drugs. Providing comprehensive Phase I-IV biopharmaceutical drug development in over 80 countries, we are dedicated to being innovative, and to delivering unmatched scientific expertise that improves the drug development process.

We help change people’s lives for the better every single day. It’s what we are passionate about.


PRAH (Common Stock)
Price107.78Change- 0.69
Volume517,747% Change0.64%
Intraday High109.3052 Week High112.87
Intraday Low107.2852 Week Low73.50
Today's Open108.95CurrencyUS Dollar
Previous Close108.47Exchange NASDAQ GS
Financial Status IndicatorC
09/21/18 4:00 p.m. ET


Stock chart for: PRAH.OQ.  Currently trading at $107.78 with a 52 week high of $112.87 and a 52 week low of $73.50.
PRAH (Common Stock)
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources